|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2010-12-1
|
|
pubmed:abstractText |
Androgen deprivation with gonadotropin-releasing hormone (GnRH) agonists or orchiectomy is a common but controversial treatment for prostate cancer. Uncertainties remain about its use, particularly with increasing recognition of serious side effects. In animal studies, androgens protect against colonic carcinogenesis, suggesting that androgen deprivation may increase the risk of colorectal cancer.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1460-2105
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1760-70
|
|
pubmed:dateRevised |
2011-2-1
|
|
pubmed:meshHeading |
pubmed-meshheading:21068432-Aged,
pubmed-meshheading:21068432-Androgen Antagonists,
pubmed-meshheading:21068432-Antineoplastic Agents, Hormonal,
pubmed-meshheading:21068432-Colorectal Neoplasms,
pubmed-meshheading:21068432-Dose-Response Relationship, Drug,
pubmed-meshheading:21068432-Humans,
pubmed-meshheading:21068432-Male,
pubmed-meshheading:21068432-Middle Aged,
pubmed-meshheading:21068432-Neoplasms, Hormone-Dependent,
pubmed-meshheading:21068432-Prostatic Neoplasms,
pubmed-meshheading:21068432-Quality of Life,
pubmed-meshheading:21068432-Risk Assessment,
pubmed-meshheading:21068432-Time Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology, Kantonsspital, St Gallen, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
